{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:24:45Z","timestamp":1790789085249,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.parkreldis.2007.07.001","type":"journal-article","created":{"date-parts":[[2007,8,28]],"date-time":"2007-08-28T11:27:52Z","timestamp":1188300472000},"page":"377-381","source":"Crossref","is-referenced-by-count":24,"title":["Post-hypoxic animal model of myoclonus"],"prefix":"10.1016","volume":"13","author":[{"given":"Kwok-Keung","family":"Tai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roongroj","family":"Bhidayasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel D.","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2007.07.001_bib1","series-title":"The nosology and pathophysiology of myoclonus","author":"Marsden","year":"1982"},{"key":"10.1016\/j.parkreldis.2007.07.001_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ana.410350219","article-title":"Prognostic value of myoclonus status in comatose survivors of cardiac arrest","volume":"35","author":"Wijdicks","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2007.07.001_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/brain\/86.1.111","article-title":"The syndrome of intention or action myoclonus as a sequel to hypoxic encephalopathy","volume":"86","author":"Lance","year":"1963","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2007.07.001_bib4","first-page":"157","article-title":"Posthypoxic action myoclonus: literature review update","volume":"43","author":"Fahn","year":"1986","journal-title":"Adv Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2007.07.001_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mds.870150707","article-title":"Animal model of posthypoxic myoclonus II: neurochemical, pathological, and pharmacologic characterization","volume":"15","author":"Kanthasamy","year":"2000","journal-title":"Mov Disord"},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2007.07.001_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/mds.870150706","article-title":"Animal models of posthypoxic myoclonus: I. Development and validation","volume":"15","author":"Truong","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2007.07.001_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/mds.870090214","article-title":"Novel rat cardiac arrest model of posthypoxic myoclonus","volume":"9","author":"Truong","year":"1994","journal-title":"Mov Disord"},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2007.07.001_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mds.870150707","article-title":"Animal model of posthypoxic myoclonus: II. Neurochemical, pathologic, and pharmacologic characterization","volume":"15","author":"Kanthasamy","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2007.07.001_bib9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/jcbfm.1995.31","article-title":"Development of susceptibility to audiogenic seizures following cardiac arrest cerebral ischemia in rats","volume":"15","author":"Kawai","year":"1995","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.parkreldis.2007.07.001_bib10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.brainres.2005.08.027","article-title":"Post-hypoxic myoclonus induces Fos expression in the reticular thalamic nucleus and neurons in the brainstem","volume":"1059","author":"Tai","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.parkreldis.2007.07.001_bib11","first-page":"236","article-title":"Animal models of myoclonus","volume":"3","author":"Kanthasamy","year":"1995","journal-title":"Clin Neurosci"},{"key":"10.1016\/j.parkreldis.2007.07.001_bib12","first-page":"295","article-title":"Posthypoxic myoclonus animal models","volume":"89","author":"Truong","year":"2002","journal-title":"Adv Neurol"},{"key":"10.1016\/j.parkreldis.2007.07.001_bib13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1056\/NEJM197808102990621","article-title":"Post-anoxic action myoclonus: improvement with valproic acid","volume":"299","author":"Fahn","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.parkreldis.2007.07.001_bib14","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/mds.870100514","article-title":"Effects of selective serotonergic ligands on posthypoxic audiogenic myoclonus","volume":"10","author":"Matsumoto","year":"1995","journal-title":"Mov Disord"},{"key":"10.1016\/j.parkreldis.2007.07.001_bib15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.52.1.16","article-title":"Animal model of posthypoxic myoclonus: effects of serotonergic antagonists","volume":"52","author":"Pappert","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2007.07.001_bib16","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/S0022-3565(24)38091-7","article-title":"Effect of riluzole on the neurological and neuropathological changes in an animal model of cardiac arrest-induced movement disorder","volume":"288","author":"Kanthasamy","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.parkreldis.2007.07.001_bib17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-2999(95)00741-5","article-title":"Antimyoclonic effect of gabapentin in a posthypoxic animal model of myoclonus","volume":"297","author":"Kanthasamy","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.parkreldis.2007.07.001_bib18","unstructured":"Tai KK, Truong DD. Brivaracetam is superior to levetiracetam in a rat model of post-hypoxic myoclonus. J Neural Transmission [in press]."},{"key":"10.1016\/j.parkreldis.2007.07.001_bib19","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1212\/WNL.26.9.863","article-title":"Beneficial effects of serotonin precursors in postanoxic action myoclonus","volume":"26","author":"De Lean","year":"1976","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2007.07.001_bib20","first-page":"21","article-title":"Pharmacological analysis of a case of postanoxic intention and action myoclonus","volume":"124","author":"Lhermitte","year":"1971","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.parkreldis.2007.07.001_bib21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0091-3057(94)00336-X","article-title":"Association between brain indole levels and severity of posthypoxic myoclonus in rats","volume":"50","author":"Matsumoto","year":"1995","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.parkreldis.2007.07.001_bib22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/0024-3205(86)90454-6","article-title":"The genetically epilepsy-prone rat: an overview of seizure-prone characteristics and responsiveness to anticonvulsant drugs","volume":"39","author":"Reigel","year":"1986","journal-title":"Life Sci"},{"key":"10.1016\/j.parkreldis.2007.07.001_bib23","first-page":"307","article-title":"The serotonin hypothesis of myoclonus from the perspective of neuronal rhythmicity","volume":"89","author":"Welsh","year":"2002","journal-title":"Adv Neurol"},{"key":"10.1016\/j.parkreldis.2007.07.001_bib24","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0306-4522(97)00297-2","article-title":"Removal of the inferior olive abolishes myoclonic seizures associated with a loss of olivary serotonin","volume":"82","author":"Welsh","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.parkreldis.2007.07.001_bib25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0014-2999(94)00743-Q","article-title":"Strychnine-insensitive glycine site antagonists attenuate a cardiac arrest-induced movement disorder","volume":"275","author":"Matsumoto","year":"1995","journal-title":"Eur J Pharmacol"},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2007.07.001_bib26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/mds.870150709","article-title":"Involvement of GABA(A) receptors in myoclonus","volume":"15","author":"Matsumoto","year":"2000","journal-title":"Mov Disord"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802007001162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802007001162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T18:03:12Z","timestamp":1737396192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802007001162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S1353802007001162"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2007.07.001","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}